Enanta Pharmaceuticals Inc (NASDAQ: ENTA) stock closed at $15.16 on 9/29/25 after a major increase of 91.9%. Moreover, trading volume in this advance was exceptionally high at 3020% of normal. The stock has risen 98.4% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Enanta Pharmaceuticals has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Enanta Pharmaceuticals has a poor Appreciation Score of 22 but a very high Power Rating of 85, resulting in the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment